AgingResearch.NewsJoin free

No phaseCompleted

Validation of a Molecular Signature for Early Detection of Colorectal Cancer

Sponsor
ADVANCED MARKER DISCOVERY S.L. (Industry)
Enrolment
3,421 enrolled
Conditions
Colorectal Cancer Screening; Advanced Adenomas (AA)
Interventions
blood sampling; stool sampling; colonoscopy
Ages
adults, older adults
Registry
NCT06738511

Full record on ClinicalTrials.gov

From the registry

The goal of this Multicentre and international prospective study is to validate a molecular signature using plasma samples in average-risk population for colorectal cancer who undergo colonoscopy in a screening setting. The main question it aims to answer is: Does molecular signature in plasma sample have higher diagnostic accuracy than FIT for early detection of colorectal cancer? Participants who already have a colonoscopy as part of their regular medical care for colorectal cancer screening will provide a stool sample and a plasma sample.

Primary outcomes

  • Demonstrate the diagnosis capacity of molecular signature in plasma samples

History

  1. Registered

  2. Primary completion

  3. Started

Papers citing this trial